Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
McKinsey
Healthtrust
Fuji
Daiichi Sankyo
Teva
Julphar
Cerilliant
McKesson

Generated: August 16, 2018

DrugPatentWatch Database Preview

Drug Master Files for: Novartis Pharm

« Back to Dashboard


Novartis Pharm Drug Master Files

DMF No. Status Type Submission Date Holder Subject
3843 I II 6/16/1980 NOVARTIS PHARMACEUTICALS CORP PERSONNEL, FACILS & GEN OPERATING PROCEDURES AT EAST HANOVER, NJ.
6601 I II 9/24/1986 NOVARTIS PHARMACEUTICALS CORP PYRILAMINE BASE
6604 I II 9/24/1986 NOVARTIS PHARMACEUTICALS CORP PYRILAMINE MALEATE
6895 A II 3/26/1987 NOVARTIS PHARMA AG POLY (DL-LACTIDE-CO-GLYCOLIDE)
7513 I II 6/7/1988 NOVARTIS PHARMACEUTICALS CORP STARTING MATERIALS 1 & 3, IN NEW JERSEY AND SWITZERLAND
9017 I II 3/13/1991 NOVARTIS PHARMACEUTICALS CORP TESSALON DRUG SUBSTANCE
9643 A II 4/15/1992 NOVARTIS PHARMACEUTICALS CORP LIORESAL INTRATHECAL AMPULS/BACLOFEN
DMF No. Status Type Submission Date Holder Subject

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Teva
Accenture
Johnson and Johnson
Medtronic
Cipla
US Army
Chinese Patent Office
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.